Healthcare M&A Boom Expected to Continue Into Late 2025
PwC forecasts record healthcare deal activity will persist through the second half of the year, signaling sustained consolidation pressure across the sector.
The healthcare sector is on track for a landmark year in mergers and acquisitions, with consulting giant PwC projecting that record-setting deal activity will carry through the second half of the period. The forecast reflects deepening structural forces — cost pressures, workforce shortages, and the push for scale — that have made consolidation a strategic imperative rather than an opportunistic play for many healthcare organizations.
M&A activity in healthcare has historically accelerated when providers and payers face margin compression alongside the need to invest heavily in technology and infrastructure. The current environment appears to be no different, with dealmakers showing little appetite to slow down despite elevated interest rates that have cooled transaction volumes in other industries. That resilience speaks to healthcare's relative defensiveness as a sector and the urgency executives feel to reposition before competitive dynamics shift further.
Read more Apple Raises Mac and iPad Prices as iPhone May Be Next →
From a strategic standpoint, the persistence of deal flow into the back half of the year suggests that buyers — whether hospital systems, private equity firms, or insurers — are comfortable enough with the regulatory and financing environment to commit capital at scale. It also implies that sellers are finding valuations acceptable, a meaningful signal given that bid-ask spreads widened considerably during the post-pandemic repricing cycle.
Analysts watching the space will note that sustained M&A momentum typically reshapes care delivery models over a multi-year horizon, concentrating market power among fewer, larger entities. Whether that consolidation ultimately benefits patients through coordinated care or raises antitrust concerns for regulators remains an open and consequential question as deal volume climbs.
Continue reading at SeekingAlpha.
